In 2020, the total value of biotech equity financing in Canada, as well as the number of rounds, were slightly higher than in 2019 and the highest since 2016. Canadian companies currently have more than 700 human therapeutics in their pipelines and the country remains one of the strongest life science markets in the world. … Continue reading Canada Life Science Market Trend Analysis 2021
Even though most industries have been badly affected by the global pandemic, German life sciences thrived in 2020. The total value of private equity investments doubled compared to 2019 and was the highest since we started tracking the data. There are at least 840 human therapeutics in different stages of development which makes Germany one … Continue reading Germany Life Science Market Trend Analysis 2021
We are proud to present the annual life science market trend report for Switzerland that was compiled in cooperation with our partners: the Swiss Biotech Association, Basel Area Business & Innovation, Life Science Zurich, Canton of Zurich, and the City of Zurich. The report shows the thriving nature of the Swiss biotech industry that proved … Continue reading Switzerland Life Science Market Trend Analysis 2021
2020 was a great year for the British biotech industry. The total value of private equity investments was twice as high compared to 2019 and exceeded the 2018 level that had been the highest since we begun tracking data. The UK remains the largest life science market in Europe when it comes to the number … Continue reading United Kingdom Life Science Trend Analysis 2021
Wednesday, 3 March 2021 Biotechgate, the leading global biotech database, presents their annual Trend Analysis Report 2021 of the Dutch life sciences sector. The report shows the resilience of the Dutch biotech sector. Although the coronavirus had a negative impact on the amount of clinical trials, biotech companies attracted double the amount of venture … Continue reading Dutch Life Sciences Trend Analysis 2021 – Biotech Companies Show To Be Resilient And See Venture Financing Grow In 2020
Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.
This month we are presenting the annual life science market trend report for Germany that was created thanks to the cooperation with our partners: BIO Deutschland, HEALTH MADE IN GERMANY, Cluster Biotechnology North Rhine-Westphalia, and BioRN. With about 1,200 active companies, over 500 assets available for licensing and 478 million dollars of venture capital attracted … Continue reading German Life Science Market Trend Analysis 2020
Biotechgate presents the annual Trend Analysis Report 2020 for the Dutch life sciences sector. The report shows a stable number of life science companies and a sector which has grown in maturity. Biotech companies were successful in attracting venture capital; 2019 is a record year for venture financing.
The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the … Continue reading Denmark Life Science Market Trend Analysis 2020
South Korea is one of the most active life science markets in the world. In 2019, USD 806.7m was invested in Korean private biotech companies that accounted for almost 4% of the total global biotech financing amount. The country currently offers hundreds of biotech and medtech assets to out-licence. We would like to thank our … Continue reading Korean Life Science Market Trend Analysis 2020